We believe that understanding
and managing the cost and quality of health care delivery depends
on subdividing health care services into disease "product lines."
Within disease product lines, the clinical practice and capital
expenditure decisions become specific enough to evaluate the costs
and benefits of alternative choices. Therefore, a disease product
line approach helps introduce accountability for cost and quality
We made a corporate decision to concentrate on developing each
product line in a complete and comprehensive manner. Tools for
inpatient and outpatient obstetrics and the Neonatal Intensive
Care Unit (NICU) are currently available. We expect to offer
similar tools for other product lines in the future.
Principals of HSE |
Our Approach |